The Nasdaq Stock Market -- New York
About The Nasdaq Stock Market -- New York
Nasdaq, a key driver of global capital formation, is the world's largest electronic stock market. With nearly 4,000 companies, Nasdaq lists more companies and trades more shares per day than any other U.S. market. Over the past five years, Nasdaq has outpaced all other U.S. markets in listing IPOs. It is home to category-defining companies that are leaders across all areas of business including technology, retail, communications, financial services, media and biotechnology industries. For more information about Nasdaq, visit the Nasdaq Web site at www.nasdaq.comMedia Contact:
Mike DeMeo Associate Director Nasdaq Corporate Communications 1500 Broadway New York, NY 10036 Telephone: 212-768-2562 Fax: 212-827-0365 michael.demeo@nasdaq.com
Nasdaq-Contact:
Eric Bernbach Corporate Client Group The Nasdaq Stock Market One Liberty Plaza New York, NY 10006 Telephone: 800-233-5494 Fax: 212-709-2494 eric.bernbach@nasdaq.com Non-U.S. Contact:
Isabella Schidrich or Vijay Singh Nasdaq International Durrant House, 8/13 Chiswell Str. London, EC1Y 4XY United Kingdom Telephone: 44-171-374-6969 Fax: 44-171-374-4488
Last Updated: 05-15-03
573 articles about The Nasdaq Stock Market -- New York
-
Citius Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements - July 13, 2020
7/13/2020
Citius Pharmaceuticals, Inc. announced that it received notice from The Nasdaq Stock Market LLC on July10, 2020 indicating that the Company has regained compliance with the minimum bid price requirement under NASDAQ Listing Rule 5550 for continued listing on The NASDAQ Capital Market.
-
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 31, 2019
5/31/2019
PTC Therapeutics, Inc. announced that on May 20, 2019 it approved non-statutory stock options to purchase an aggregate of 76,250 shares of its common stock to 15 new employees.
-
Realm Therapeutics Announces Receipt of Nasdaq Listing Determination and Requests Hearing
4/5/2019
Realm Therapeutics plc announced that the Company received written notice from the Listing Qualifications Staff of The Nasdaq Stock Market LLC indicating that, based upon the Company's recent Assets Disposal, the Staff believes the Company is a "shell company" and, as such, the continued listing of American Depositary Shares representing the Company's ordinary shares on Nasdaq is no longer warranted.
-
NASDAQ Grants The Nasdaq Stock Market -- New York 180-Day Extension to Regain Compliance with Minimum Bid Price Rule
12/17/2010
-
Poniard Pharmaceuticals, Inc. Announces Plan for Voluntary Prepayment of Term Loan and Transfer to Nasdaq Capital Market
12/16/2010
-
The Nasdaq Stock Market -- New York Gives Dynatronics Corporation a Second Six-Month Extension for Minimum Bid Price Compliance
12/15/2010
-
Henry Schein, Inc. to Present at the NASDAQ OMX 25th Investor Program
12/7/2010
-
GenVec Inc. Announces Listing Transfer to the Nasdaq Capital Market
11/8/2010
-
The Nasdaq Stock Market -- New York Grants Cell Therapeutics, Inc. 180-Day Extension to Regain Compliance With Minimum Bid Price Rule
11/3/2010
-
Orexigen Therapeutics, Inc. Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
10/29/2010
-
EntreMed, Inc. Receives Notice of NASDAQ Compliance
10/15/2010
-
For the Fifth Straight Year Hologic, Inc. Will Ring the Opening Bell at NASDAQ Ceremony Marking the Start of Breast Cancer Awareness Month
9/30/2010
-
NeoStem, Inc. Presented at NASDAQ MarketSite in New York to Discuss Entry Into Merger Agreement With Progenitor Cell Therapy
9/27/2010
-
iCAD, Inc. to Ring The Nasdaq Stock Market -- New York Closing Bell in Recognition of Prostate Cancer Awareness Month
8/31/2010
-
EntreMed, Inc. Receives The Nasdaq Stock Market -- New York Listing Rule 5550(b)(2) Determination Letter
8/23/2010
-
EntreMed, Inc. Receives The Nasdaq Stock Market -- New York Listing Rule 5550(b)(2) Determination Letter
8/20/2010
-
EntreMed, Inc. Regains Compliance With NASDAQ Minimum Bid Price Rule
7/20/2010
-
Endo Pharmaceuticals Recognizes 10 Years as a Public Company by Ringing the NASDAQ Opening Bell
7/19/2010
-
Progen Pharmaceuticals Limited Receives Delisting Notification from The Nasdaq Stock Market -- New York
6/24/2010
-
Insmed Incorporated Receives NASDAQ Deficiency Notice Relating to Minimum Bid Price
6/22/2010